全文获取类型
收费全文 | 27175篇 |
免费 | 1278篇 |
国内免费 | 211篇 |
专业分类
耳鼻咽喉 | 214篇 |
儿科学 | 658篇 |
妇产科学 | 218篇 |
基础医学 | 3477篇 |
口腔科学 | 455篇 |
临床医学 | 1716篇 |
内科学 | 7444篇 |
皮肤病学 | 402篇 |
神经病学 | 1765篇 |
特种医学 | 1238篇 |
外科学 | 4841篇 |
综合类 | 107篇 |
一般理论 | 1篇 |
预防医学 | 746篇 |
眼科学 | 369篇 |
药学 | 1636篇 |
中国医学 | 44篇 |
肿瘤学 | 3333篇 |
出版年
2023年 | 196篇 |
2022年 | 375篇 |
2021年 | 668篇 |
2020年 | 341篇 |
2019年 | 510篇 |
2018年 | 643篇 |
2017年 | 508篇 |
2016年 | 656篇 |
2015年 | 681篇 |
2014年 | 949篇 |
2013年 | 1061篇 |
2012年 | 1705篇 |
2011年 | 1925篇 |
2010年 | 1081篇 |
2009年 | 906篇 |
2008年 | 1553篇 |
2007年 | 1776篇 |
2006年 | 1772篇 |
2005年 | 1759篇 |
2004年 | 1699篇 |
2003年 | 1597篇 |
2002年 | 1604篇 |
2001年 | 387篇 |
2000年 | 343篇 |
1999年 | 395篇 |
1998年 | 355篇 |
1997年 | 308篇 |
1996年 | 275篇 |
1995年 | 228篇 |
1994年 | 218篇 |
1993年 | 195篇 |
1992年 | 232篇 |
1991年 | 212篇 |
1990年 | 194篇 |
1989年 | 171篇 |
1988年 | 163篇 |
1987年 | 122篇 |
1986年 | 106篇 |
1985年 | 98篇 |
1984年 | 97篇 |
1983年 | 67篇 |
1982年 | 55篇 |
1981年 | 55篇 |
1980年 | 38篇 |
1979年 | 49篇 |
1978年 | 32篇 |
1977年 | 44篇 |
1975年 | 33篇 |
1973年 | 24篇 |
1972年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
Tsuyoshi Imamura Yasufumi Doi Toshiharu Ninomiya Jun Hata Masaharu Nagata Fumie Ikeda Naoko Mukai Yoichiro Hirakawa Daigo Yoshida Masayo Fukuhara Takanari Kitazono Yutaka Kiyohara 《Atherosclerosis》2014
Background and purpose
It has not been fully determined whether non-high-density lipoprotein cholesterol (non-HDLC) levels are involved in vascular events, especially stroke, in general Asian populations. We evaluated the association between non-HDLC levels and the risk of type-specific cardiovascular disease in a prospective cohort study in Japan.Methods
A total of 2452 community-dwelling Japanese subjects aged ≥40 years were followed prospectively for 24 years.Results
The age- and sex-adjusted incidence of coronary heart diseases (CHD) significantly increased with elevating non-HDLC levels (P for trend < 0.001), but no such association was observed for ischemic and hemorrhagic strokes. With regard to ischemic stroke subtypes, the age- and sex-adjusted incidence of lacunar infarction significantly increased with elevating non-HDLC levels (P for trend < 0.01), and such tendency was seen for atherothrombotic infarction (P for trend = 0.098), while a significant inverse association was observed for cardioembolic infarction (P for trend = 0.007). After adjustment for confounders, namely, age, sex, diabetes, body mass index, systolic blood pressure, electrocardiogram abnormalities, current drinking, current smoking, and regular exercise, the associations remained significant for CHD [adjusted hazard ratio (HR) for a 1 standard deviation of non-HDLC concentrations = 1.17, 95% confidence interval (CI) = 1.02 to 1.35], atherothrombotic infarction (adjusted HR = 1.39, 95% CI = 1.09 to 1.79), and cardioembolic infarction (adjusted HR = 0.64, 95% CI = 0.47 to 0.85).Conclusions
Our findings suggest that elevated non-HDLC levels are a significant risk factor for the development of atherothrombotic infarction as well as CHD but reduce the risk of cardioembolic infarction in the general Japanese population. 相似文献972.
Hiroyuki Murata Soichiro Ito Hiroyuki Kusuhara Yukihiro Nomura Toshio Taniguchi 《Journal of pharmaceutical sciences》2019,108(12):3898-3902
It is known that potent inhibition of organic-anion-transporting polypeptide (OATP)1B1 increases exposure to statins, leading to severe adverse effects. The aim of this study was to propose a parameter and its criteria in OATP1B1 inhibition assay at the early drug discovery stage to avoid compounds with the risk of statin-related adverse effects. According to drug label information, most compounds classified as “contraindicated” or “should be avoided” when administered concomitantly with statins increased their AUCs more than 4-fold. Generally, R values where R = 1 + plasma unbound fraction (fu) × maximum inhibitor concentration at the inlet to the liver/IC50 are used to evaluate the extent of clinical drug interaction. However, clinical doses and Cmax cannot be determined at the screening stage. Therefore, we estimated the correlations between change in AUC of statins concomitantly administered with OATP1B1 inhibitors and various parameters including fu/IC50. Cyclosporin A, rifampicin, and telaprevir increased the AUC of statins more than 4-fold and fu/IC50 of these compounds was >0.1 L/μmol. On the other hand, fu/IC50 of other compounds was ≤0.03 L/μmol. This study indicates that fu/IC50 is a useful parameter to avoid compounds that seriously affect statin potency through interaction with OATP1B1 at the screening stage. 相似文献
973.
974.
Kobayashi Kentaro Manabe Osamu Hirata Kenji Yamaguchi Shigeru Kobayashi Hiroyuki Terasaka Shunsuke Toyonaga Takuya Furuya Sho Magota Keiichi Kuge Yuji Kudo Kohsuke Shiga Tohru Tamaki Nagara 《European journal of nuclear medicine and molecular imaging》2020,47(8):1833-1842
European Journal of Nuclear Medicine and Molecular Imaging - 18F-fluoromisonidazole (18F-FMISO) is the most widely used positron emission tomography (PET) tracer for imaging tumor hypoxia. Previous... 相似文献
975.
Fujii Hiroyuki Tsuji Taisuke Yuba Tatsuya Tanaka Shunya Suga Yoshifumi Matsuyama Aosa Omura Ayaka Shiotsu Shinsuke Takumi Chieko Ono Seiko Horiguchi Masahito Hiraoka Noriya 《Clinical rheumatology》2020,39(11):3171-3175
Clinical Rheumatology - We treated two patients with severe respiratory failure due to coronavirus disease 2019 (COVID-19). Case 1 was a 73-year-old woman, and Case 2 was a 65-year-old-man. Neither... 相似文献
976.
977.
978.
Maho Suzukawa Nobuharu Ohshima Hiroyuki Tashimo Isao Asari Nobuyuki Kobayashi Shunsuke Shoji Shigeto Tohma Ken Ohta 《Internal medicine (Tokyo, Japan)》2020,59(22):2849
Objective Mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, is effective for treating eosinophilic severe asthma. However, there is a need for more biomarkers that can predict the patient response to mepolizumab before starting therapy. This study aimed to identify a new biomarker in the serum that is able to accurately predict the responsiveness to mepolizumab. Methods This study enrolled 11 patients who had all been diagnosed with severe eosinophilic asthma and were then administered mepolizumab every 4 weeks for at least 4 months. Blood samples were collected, and pulmonary function tests and questionnaires were administered at baseline and after 4, 8 and 16 weeks of treatment. The response to mepolizumab was then assessed based on the difference in the Asthma Quality of Life Questionnaire (AQLQ) score after 16 weeks of mepolizumab therapy compared with that at baseline. Patients with an increase in the AQLQ score of more than 0.5 were defined as responders. The cytokine levels in the blood were measured by LUMINEX 200 and ELISA. Results There were 6 responders and 5 non-responders. The responders showed a significantly lower serum level of chemokine (C-C motif) ligand 4/macrophage inflammatory protein-1β (CCL4/MIP-1β) at baseline compared to the non-responders. Receiver operating characteristic curves to distinguish responders from non-responders using the baseline serum CCL4/MIP-1β level showed a good area under the curve of 0.9. The non-responders showed a significant increase in the level of CCL4/MIP-1β after 4 weeks compared to the baseline. Conclusion A low baseline serum CCL4/MIP-1β level may be useful for predicting a good mepolizumab response in severe eosinophilic asthma. 相似文献
979.
Yusuke Satta Masaki Yamashita Yasumasa Matsuo Hirofumi Kiyokawa Yoshinori Sato Hiromu Takemura Hiroyuki Kunishima Hiroshi Yasuda Fumio Itoh 《Internal medicine (Tokyo, Japan)》2020,59(22):2811
Objective Gastrointestinal lesions of non-tuberculous mycobacteria (NTM) are regarded as opportunistic infections. A large number of positive specimens of NTM were identified in an intestinal fluid culture in the endoscopy unit and it was considered to be a pseudo-outbreak. Methods We reviewed the hospital, laboratory, and colonoscopy records of 263 consecutive patients whose intestinal fluids were analyzed for a mycobacterial culture by colonoscopy at St. Marianna University Hospital, between January 2009 and December 2018. The endoscopy reprocessing procedures were reviewed and samples of water used in the endoscopy unit were cultured. Results An intestinal fluid culture of 154 (58.6%) patients tested positive for NTM (M. intracellulare; 125 cases, M. gordonae; 14 cases, M. avium; 4 cases, M. abscessus; 3 cases, and 8 other cases). In 182 cases (69.2%), an intestinal mucosal culture was performed simultaneously with a fluid culture and tested positive for NTM in 2 cases. Next, we examined the endoscopy unit for any possible environmental contamination. NTM were detected in the tap water used to prepare the antifoaming solution in the endoscopy unit. The water faucets in the endoscopy unit were considered to be the source of the contamination of NTMs. Conclusion We observed that a large number of cases tested positive due to contaminated water that had been used in an endoscopy unit, thus leading to a pseudo-outbreak of NTM. 相似文献
980.
Satona Tanaka Minoru Aoki Hiroyuki Ishikawa Yosuke Otake 《General thoracic and cardiovascular surgery》2014,62(6):370-375